RECRUITINGINTERVENTIONAL

Simple Meal Management Using Automated Insulin Delivery System

Evaluation on Glycemic Control Using Two Different Meal Announcement Plans in Adolescents With Type 1 Diabetes on Minimed 780G Hybrid Closed Loop System

About This Trial

Carbohydrate counting is an essential component of diabetes management in both adults and children, and together with an intensive insulin plan and increased blood glucose monitoring was associated with lower HbA1c. Carbohydrate counting is perceived as one of the most burdensome tasks in T1D and is frequently done inconsistently and with poor accuracy A recent analysis confirms that MiniMed™ Advaced Hybrid closed loop (AHCL) system is designed for optimal performance with meal announcement. Nonetheless, when meals containing \< 80 grams of carbohydrates are consumed with announcement of meals at will, there is a slight reduction in the number of daily boluses with no decline in glycemic control, yet markedly less diabetes related distress and improved treatment satisfaction TIR of 78.1% in unannounced meals compared with 78.8% with announced meals .

Who May Be Eligible (Plain English)

Who May Qualify: 1. Clinical diagnosis of type 1 diabetes \>1 year prior to consent date. Diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required. 2. Age 12 and above at the initiation of the system 3. Total daily insulin use of great than 8.0 units per day over a 1-week period 4. Willing and able (access to internet from home) to download information into the Medtronic CareLink software 5. Clinically able to start the AHCL system Who Should NOT Join This Trial: 1. Pregnancy 2. Untreated diabetes retinopathy, or other causes that in the investigator's opinion , precludes the individual from participating in the trial. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: 1. Clinical diagnosis of type 1 diabetes \>1 year prior to consent date. Diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required. 2. Age 12 and above at the initiation of the system 3. Total daily insulin use of great than 8.0 units per day over a 1-week period 4. Willing and able (access to internet from home) to download information into the Medtronic CareLink software 5. Clinically able to start the AHCL system Exclusion Criteria: 1. Pregnancy 2. Untreated diabetes retinopathy, or other causes that in the investigator's opinion , precludes the individual from participating in the trial.

Treatments Being Tested

OTHER

Simple meal management

* Regular meal: Total Carbs per Day x 0.6 / 3 * Large meal: Total Carbs per Day x 0.6 / 3 x 1.5 * Small (Snack) meal: Total Carbs per Day x 0.6 / 3 x 1.5

OTHER

Precise meal management

precise carbohydrate counting for each meal

Locations (1)

Sidra Medicine

Doha, Qa, Qatar